| 1 | Vaccines: for human medicineHS6 300220 - six-digit product code | $6.9B | 46.6% | 1.3 | High attention |
|---|
| 2 | Medicaments: containing hormones (excluding insulin), (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail saleHS6 300339 - six-digit product code | $3.4B | 0% | 2.5 | High attention |
|---|
| 3 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail saleHS6 300490 - six-digit product code | $18.6B | 84% | 0.8 | Watch |
|---|
| 4 | Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail saleHS6 300214 - six-digit product code | $2.3B | 48.5% | 0.7 | Stable |
|---|
| 5 | Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereofHS6 293359 - six-digit product code | $912.6M | 78.9% | 0.5 | High attention |
|---|
| 6 | Electronic integrated circuits: n.e.c. in heading no. 8542HS6 854239 - six-digit product code | $2.3B | 0% | 3.1 | High attention |
|---|
| 7 | Heterocyclic compounds: n.e.c. in headings no. 2933HS6 293399 - six-digit product code | $464.5M | 89.4% | 0.9 | Critical attention |
|---|
| 8 | Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail saleHS6 300215 - six-digit product code | $5.2B | 93.7% | 1 | Critical attention |
|---|
| 9 | Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)HS6 293379 - six-digit product code | $1.3B | 96.4% | 1.8 | High attention |
|---|
| 10 | Sulphonamides: n.e.c. in heading no. 2935HS6 293590 - six-digit product code | $297.8M | 88.9% | 0.9 | Critical attention |
|---|